UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 79

Sortiert nach

Treatment-induced hypothyroidism in head-and-neck cancer – Is it a crystal ball?

Cancer research, statistics, and treatment (Online), 2018-01, Vol.1 (2), p.118-120

Tarun Puri

2018

Link zum Volltext

Verfügbarkeit prüfen

Clinical outcomes of ramucirumab plus docetaxel in the treatment of patients with non-small cell lung cancer after immunotherapy: a systematic literature review

Frontiers in oncology, 2023-09, Vol.13, p.1247879-1247879

2023

Link zum Volltext

Verfügbarkeit prüfen

Current perspectives on the management of patients with advanced RET -driven thyroid cancer in Europe

Frontiers in oncology, 2023-05, Vol.13, p.1141314-1141314

2023

Link zum Volltext

Verfügbarkeit prüfen

East Asian Subgroup Analysis of a Randomized, Double-Blind, Phase 3 Study of Docetaxel and Ramucirumab Versus Docetaxel and Placebo in the Treatment of Stage IV Non-small Cell Lung Cancer Following Disease Progression after One Prior Platinum-Based Therapy (REVEL)

Cancer Research and Treatment, 2016, 48(4), , pp.1177-1186

2016

Link zum Volltext

Verfügbarkeit prüfen

RET Fusion-Positive Non-small Cell Lung Cancer: The Evolving Treatment Landscape

The oncologist (Dayton, Ohio), 2023-05, Vol.28 (5), p.402-413

2023

Link zum Volltext

Verfügbarkeit prüfen

Holocord low grade astrocytoma – Role of radical irradiation and chemotherapy

Journal of Egyptian National Cancer Institute, 2015-06, Vol.27 (2), p.105-108

2015

Link zum Volltext

Verfügbarkeit prüfen

MGMT gene promoter methylation in pediatric glioblastomas

Child's nervous system, 2010-11, Vol.26 (11), p.1613-1618

2010

Link zum Volltext

Verfügbarkeit prüfen

Breast cancer with inguinal node recurrence

Journal of Egyptian National Cancer Institute, 2015-03, Vol.27 (1), p.41-43

2015

Link zum Volltext

Verfügbarkeit prüfen

Cost effectiveness of concurrent gemcitabine and cisplatin and radiation followed by adjuvant gemcitabine and cisplatin in stages IIB–IVA cervical cancer

Gynecologic oncology reports, 2014-12, Vol.10 (C), p.36-37

2014

Link zum Volltext

Verfügbarkeit prüfen

Atypical teratoid rhabdoid tumor of the brain: case series and review of literature

Child's nervous system, 2009-11, Vol.25 (11), p.1495-1500

2009

Link zum Volltext

Verfügbarkeit prüfen

Randomized Phase II Trial of Gefitinib With and Without Pemetrexed as First-Line Therapy in Patients With Advanced Nonsquamous Non-Small-Cell Lung Cancer With Activating Epidermal Growth Factor Receptor Mutations

Journal of clinical oncology, 2016-09, Vol.34 (27), p.3258-3266

2016

Link zum Volltext

Verfügbarkeit prüfen

Selpercatinib in Patients With RET Fusion-Positive Non-Small-Cell Lung Cancer: Updated Safety and Efficacy From the Registrational LIBRETTO-001 Phase I/II Trial

Journal of clinical oncology, 2023-01, Vol.41 (2), p.385-394

2023

Link zum Volltext

Verfügbarkeit prüfen

Overall Treatment Strategy for Patients With Metastatic NSCLC With Activating EGFR Mutations

Clinical lung cancer, 2022-01, Vol.23 (1), p.e69-e82

2022

Link zum Volltext

Verfügbarkeit prüfen

A phase 2 study of sequential neoadjuvant chemotherapy with gemcitabine and doxorubicin followed by gemcitabine and cisplatin in patients with large or locally advanced operable breast cancer: results from long-term follow-up

Breast cancer (Tokyo, Japan), 2013-10, Vol.20 (4), p.357-362

2013

Link zum Volltext

Verfügbarkeit prüfen

First-Line Selpercatinib or Chemotherapy and Pembrolizumab in RET Fusion–Positive NSCLC

The New England journal of medicine, 2023-11, Vol.389 (20), p.1839-1850

2023

Link zum Volltext

Verfügbarkeit prüfen

Different faces of cutaneous Hodgkin′s disease

Indian journal of dermatopathology and diagnostic dermatology, 2014, Vol.1 (2), p.79-82

2014

Link zum Volltext

Verfügbarkeit prüfen

A phase Ⅱ study of gemcitabine and carboplatin combination chemotherapy in gallbladder carcinoma

Hepatobiliary & pancreatic diseases international, 2006-02, Vol.5 (1), p.110-114

2006

Link zum Volltext

Verfügbarkeit prüfen

Primary renal osteosarcoma with systemic dissemination

Saudi journal of kidney diseases and transplantation, 2012-01, Vol.23 (1), p.114-116

2012

Link zum Volltext

Verfügbarkeit prüfen

Epithelial-myoepithelial carcinoma of the base of tongue: Pathology and management

Indian journal of cancer, 2004-07, Vol.41 (3), p.138-140

Puri Tarun, Singh Kishore, Sharma Daya Nand, Khurana Nita

2004

Link zum Volltext

Verfügbarkeit prüfen

Patient Characteristics, Testing and Treatment Patterns, and Outcomes in EGFR-Mutated Advanced Non-Small Cell Lung Cancer: A Multinational, Real-World Study

Advances in therapy, 2023-07, Vol.40 (7), p.3135-3168

2023

Link zum Volltext

Verfügbarkeit prüfen

A Randomized Phase 2 Study of Gefitinib With or Without Pemetrexed as First-line Treatment in Nonsquamous NSCLC With EGFR Mutation: Final Overall Survival and Biomarker Analysis

Journal of thoracic oncology, 2020-01, Vol.15 (1), p.91-100

2020

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of first-line therapies in EGFR -mutated advanced non-small-cell lung cancer: a network meta-analysis

Future oncology (London, England), 2022-05, Vol.18 (16), p.2007-2028

2022

Link zum Volltext

Verfügbarkeit prüfen

Reply to A. Ota et al, Y.H. Kim, and N. Van Der Steen et al

Journal of clinical oncology, 2017-02, Vol.35 (6), p.694-695

2017

Link zum Volltext

Verfügbarkeit prüfen

Anaplastic meningioma in an adolescent: a report of a rare case and brief review of literature

Child's nervous system, 2009-02, Vol.25 (2), p.241-245

2009

Link zum Volltext

Verfügbarkeit prüfen

A Review of Regimens Combining Pemetrexed With an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in the Treatment of Advanced Nonsquamous Non–Small-Cell Lung Cancer

Clinical lung cancer, 2018-01, Vol.19 (1), p.27-34

2018

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 79

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(72)
Mit Volltextzugriff
(77)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(43)
Science & Technology
(43)
Humans
(41)
Oncology
(26)
Female
(24)
Male
(21)
Adult
(16)
Middle Aged
(16)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(14)
Aged
(13)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(13)
Lung Neoplasms - Drug Therapy
(13)
Adolescent
(8)
Cancer
(8)
Care And Treatment
(8)
Case Studies
(8)
Diagnosis
(8)
Medicine
(8)
Medicine & Public Health
(8)
Neoplasm Staging
(8)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Treatment-induced hypothyroidism in head-and-neck cancer – Is it a crystal ball?

Clinical outcomes of ramucirumab plus docetaxel in the treatment of patients with non-small cell lung cancer after immunotherapy: a systematic literature review

Current perspectives on the management of patients with advanced RET -driven thyroid cancer in Europe

East Asian Subgroup Analysis of a Randomized, Double-Blind, Phase 3 Study of Docetaxel and Ramucirumab Versus Docetaxel and Placebo in the Treatment of Stage IV Non-small Cell Lung Cancer Following Disease Progression after One Prior Platinum-Based Therapy (REVEL)

RET Fusion-Positive Non-small Cell Lung Cancer: The Evolving Treatment Landscape

Holocord low grade astrocytoma – Role of radical irradiation and chemotherapy

MGMT gene promoter methylation in pediatric glioblastomas

Breast cancer with inguinal node recurrence

Cost effectiveness of concurrent gemcitabine and cisplatin and radiation followed by adjuvant gemcitabine and cisplatin in stages IIB–IVA cervical cancer

Atypical teratoid rhabdoid tumor of the brain: case series and review of literature

Randomized Phase II Trial of Gefitinib With and Without Pemetrexed as First-Line Therapy in Patients With Advanced Nonsquamous Non-Small-Cell Lung Cancer With Activating Epidermal Growth Factor Receptor Mutations

Selpercatinib in Patients With RET Fusion-Positive Non-Small-Cell Lung Cancer: Updated Safety and Efficacy From the Registrational LIBRETTO-001 Phase I/II Trial

Overall Treatment Strategy for Patients With Metastatic NSCLC With Activating EGFR Mutations

A phase 2 study of sequential neoadjuvant chemotherapy with gemcitabine and doxorubicin followed by gemcitabine and cisplatin in patients with large or locally advanced operable breast cancer: results from long-term follow-up

First-Line Selpercatinib or Chemotherapy and Pembrolizumab in RET Fusion–Positive NSCLC

Different faces of cutaneous Hodgkin′s disease

A phase Ⅱ study of gemcitabine and carboplatin combination chemotherapy in gallbladder carcinoma

Primary renal osteosarcoma with systemic dissemination

Epithelial-myoepithelial carcinoma of the base of tongue: Pathology and management

Patient Characteristics, Testing and Treatment Patterns, and Outcomes in EGFR-Mutated Advanced Non-Small Cell Lung Cancer: A Multinational, Real-World Study

A Randomized Phase 2 Study of Gefitinib With or Without Pemetrexed as First-line Treatment in Nonsquamous NSCLC With EGFR Mutation: Final Overall Survival and Biomarker Analysis

Efficacy and safety of first-line therapies in EGFR -mutated advanced non-small-cell lung cancer: a network meta-analysis

Reply to A. Ota et al, Y.H. Kim, and N. Van Der Steen et al

Anaplastic meningioma in an adolescent: a report of a rare case and brief review of literature

A Review of Regimens Combining Pemetrexed With an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in the Treatment of Advanced Nonsquamous Non–Small-Cell Lung Cancer

Suchergebnisse filtern